1. Home
  2. PHVS vs GIC Comparison

PHVS vs GIC Comparison

Compare PHVS & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • GIC
  • Stock Information
  • Founded
  • PHVS 2015
  • GIC 1949
  • Country
  • PHVS Switzerland
  • GIC United States
  • Employees
  • PHVS N/A
  • GIC N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • GIC Industrial Machinery/Components
  • Sector
  • PHVS Health Care
  • GIC Industrials
  • Exchange
  • PHVS Nasdaq
  • GIC Nasdaq
  • Market Cap
  • PHVS 1.6B
  • GIC 1.3B
  • IPO Year
  • PHVS 2021
  • GIC 1995
  • Fundamental
  • Price
  • PHVS $22.08
  • GIC $28.75
  • Analyst Decision
  • PHVS Buy
  • GIC
  • Analyst Count
  • PHVS 6
  • GIC 0
  • Target Price
  • PHVS $36.50
  • GIC N/A
  • AVG Volume (30 Days)
  • PHVS 217.1K
  • GIC 86.4K
  • Earning Date
  • PHVS 11-12-2025
  • GIC 10-28-2025
  • Dividend Yield
  • PHVS N/A
  • GIC 2.96%
  • EPS Growth
  • PHVS N/A
  • GIC N/A
  • EPS
  • PHVS N/A
  • GIC 1.71
  • Revenue
  • PHVS N/A
  • GIC $1,324,600,000.00
  • Revenue This Year
  • PHVS N/A
  • GIC $4.80
  • Revenue Next Year
  • PHVS N/A
  • GIC $3.70
  • P/E Ratio
  • PHVS N/A
  • GIC $20.59
  • Revenue Growth
  • PHVS N/A
  • GIC N/A
  • 52 Week Low
  • PHVS $11.51
  • GIC $20.79
  • 52 Week High
  • PHVS $26.33
  • GIC $38.79
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 49.23
  • GIC 50.28
  • Support Level
  • PHVS $22.38
  • GIC $34.41
  • Resistance Level
  • PHVS $23.64
  • GIC $35.50
  • Average True Range (ATR)
  • PHVS 1.28
  • GIC 0.79
  • MACD
  • PHVS 0.04
  • GIC 0.06
  • Stochastic Oscillator
  • PHVS 61.27
  • GIC 81.71

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

Share on Social Networks: